NUDT15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.82540005333465E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.40199998674728E-09 |
Normal-vs-Stage2 |
2.38379999999427E-05 |
Normal-vs-Stage3 |
3.93590000002941E-06 |
Normal-vs-Stage4 |
1.499860E-03 |
Stage1-vs-Stage2 |
9.956800E-01 |
Stage1-vs-Stage3 |
5.687800E-01 |
Stage1-vs-Stage4 |
7.918800E-01 |
Stage2-vs-Stage3 |
6.617600E-01 |
Stage2-vs-Stage4 |
8.061400E-01 |
Stage3-vs-Stage4 |
5.676400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.55219956279973E-10 |
Normal-vs-AfricanAmerican |
5.55719999999482E-05 |
Normal-vs-Asian |
6.464500E-03 |
Caucasian-vs-AfricanAmerican |
2.703800E-02 |
Caucasian-vs-Asian |
7.421800E-01 |
AfricanAmerican-vs-Asian |
6.620000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.5301999667372E-09 |
Normal-vs-Female |
1.04059999950223E-07 |
Male-vs-Female |
7.272400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.21289999990937E-07 |
Normal-vs-Extreme_Weight |
1.06340000138871E-08 |
Normal-vs-Obese |
2.73629999769653E-08 |
Normal-vs-Extreme_Obese |
4.661900E-02 |
Normal_Weight-vs-Extreme_Weight |
7.123800E-01 |
Normal_Weight-vs-Obese |
7.448000E-01 |
Normal_Weight-vs-Extreme_Obese |
5.400400E-01 |
Extreme_Weight-vs-Obese |
9.464400E-01 |
Extreme_Weight-vs-Extreme_Obese |
6.693800E-01 |
Obese-vs-Extreme_Obese |
6.119400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.54701999999229E-05 |
Normal-vs-Age(41-60Yrs) |
2.81859999995415E-06 |
Normal-vs-Age(61-80Yrs) |
3.60899976570295E-10 |
Normal-vs-Age(81-100Yrs) |
3.09970000000881E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.070000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.561200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.405000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.647500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.500000E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.785200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.05780000314581E-08 |
Normal-VS-Type2 PRCC |
1.21610055359156E-10 |
Normal-VS-KIRP CIMP |
5.008400E-04 |
Normal-VS-Unclassified PRCC |
1.53362999999462E-05 |
Type1 PRCC-VS-Type2 PRCC |
8.194300E-02 |
Type1 PRCC-VS-KIRP CIMP |
9.709600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.948600E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.970000E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.667780E-01 |
KIRP CIMP-VS-Unclassified PRCC |
8.647400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.64209998324105E-09 |
Normal-vs-N1 |
1.585400E-04 |
Normal-vs-N2 |
1.951810E-04 |
N0-vs-N1 |
3.056000E-01 |
N0-vs-N2 |
3.259600E-01 |
N1-vs-N2 |
2.337800E-01 |
|
|